Alberto Fabbri

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

Andrés JM Ferreri, Michele Reni, Marco Foppoli et al. · The Lancet · 2009 · 656 citations · Full text

Hematological Malignancy, Neuro-oncology, Lymphoid Neoplasia +9

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · The Lancet Haematology · 2016 · 582 citations · Full text

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

Andrés J.M. Ferreri, Kate Cwynarski, Elisa Jacobsen Pulczynski et al. · The Lancet Haematology · 2017 · 364 citations · Full text

Neuro-oncology, Radiation Oncology, Lymphoid Neoplasia +12

Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)

Alessandra Tucci, Maurizio Martelli, Luigi Rigacci et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2014 · 180 citations · Full text

Aging, Elderly Patients, Prognosis +16

Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi

Francesco Merli, Stefano Luminari, Alessandra Tucci et al. · Journal of Clinical Oncology · 2021 · 149 citations · Full text

Aging, Prognosis, Pathology +18